Literature DB >> 21099377

Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics.

Angèle Consoli1, Maha Benmiloud, Lee Wachtel, Dirk Dhossche, David Cohen, Olivier Bonnot.   

Abstract

OBJECTIVES: In child and adolescent psychiatry, catatonia is infrequent, but it is one of the most severe syndromes, characterized by the coexistence of psychic and motor symptoms. In this report, we explore the therapeutic experience with electroconvulsive therapy (ECT) in adolescents with catatonia.
METHODS: We review the literature (1985-2009) to clarify issues related to the use of ECT in child and adolescent patients with catatonia.
RESULTS: Electroconvulsive therapy is used as second-line management after high-dose benzodiazepine trials. Electroconvulsive therapy is an effective, safe, and useful procedure in the treatment of catatonic youngsters as reported in 59 patients. Ethical issues regarding the use of ECT are analyzed and their implications briefly discussed in the light of general medical ethics.
CONCLUSIONS: Electroconvulsive therapy is a safe and effective treatment for catatonia in children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099377     DOI: 10.1097/YCT.0b013e3181fb3924

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  14 in total

1.  Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia.

Authors:  Marie Raffin; Laetitia Zugaj-Bensaou; Nicolas Bodeau; Vanessa Milhiet; Claudine Laurent; David Cohen; Angèle Consoli
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-27       Impact factor: 4.785

Review 2.  Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.

Authors:  Federica Luchini; Pierpaolo Medda; Michela Giorgi Mariani; Mauro Mauri; Cristina Toni; Giulio Perugi
Journal:  World J Psychiatry       Date:  2015-06-22

3.  Psychosis and catatonia in fragile X: Case report and literature review.

Authors:  Tri Indah Winarni; Andrea Schneider; Neera Ghaziuddin; Andreea Seritan; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2015-08

4.  Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: a retrospective study.

Authors:  Angele Consoli; Johan Cohen; Nicolas Bodeau; Vincent Guinchat; Lee Wachtel; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-08-25       Impact factor: 4.785

Review 5.  A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders.

Authors:  Hannah DeJong; Penny Bunton; Dougal J Hare
Journal:  J Autism Dev Disord       Date:  2014-09

6.  Use of electroconvulsive therapy in an adolescent patient with catatonia.

Authors:  Sandeep Grover; Natasha Kate; Gaurav Gupta
Journal:  Indian J Psychol Med       Date:  2014-04

Review 7.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

8.  [Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].

Authors:  A Sauvaget; R Dumont; N Bukowski; O Bonnot; R Auffret; E Poulet; D Szekely; C Quiles; A Yrondi; M Plaze; W de Carvalho; A Amad; S Bulteau
Journal:  Encephale       Date:  2020-06-04       Impact factor: 1.291

9.  Case Report: A Case of Pediatric Catatonia: Role of the Lorazepam Challenge Test.

Authors:  Laura Ridgeway; Albert Okoye; Ian McClelland; Dirk Dhossche; Deniz Kutay; Mario Loureiro
Journal:  Front Psychiatry       Date:  2021-03-24       Impact factor: 4.157

10.  Electroconvulsive therapy use in adolescents: a systematic review.

Authors:  Nádia Nr Lima; Vânia B Nascimento; Jorge Ac Peixoto; Marcial M Moreira; Modesto Lr Neto; José C Almeida; Carlos Ac Vasconcelos; Saulo A Teixeira; Jucier G Júnior; Francisco Tc Junior; Diego Dm Guimarães; Aline Q Brasil; Jesus S Cartaxo; Marco Akerman; Alberto Oa Reis
Journal:  Ann Gen Psychiatry       Date:  2013-05-30       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.